Medical Developments International Bond
MVP Stock | 0.42 0.01 2.33% |
At this time, Medical Developments' Short and Long Term Debt Total is comparatively stable compared to the past year. Short Term Debt is likely to gain to about 494.4 K in 2024, whereas Net Debt is likely to drop (7.8 M) in 2024. . Medical Developments' financial risk is the risk to Medical Developments stockholders that is caused by an increase in debt.
At this time, Medical Developments' Non Current Liabilities Total is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 2.9 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 5.1 M in 2024. Medical |
Given the importance of Medical Developments' capital structure, the first step in the capital decision process is for the management of Medical Developments to decide how much external capital it will need to raise to operate in a sustainable way. Once the amount of financing is determined, management needs to examine the financial markets to determine the terms in which the company can boost capital. This move is crucial to the process because the market environment may reduce the ability of Medical Developments International to issue bonds at a reasonable cost.
Popular Name | Medical Developments International Game Technology |
Specialization | Pharmaceuticals, Biotechnology & Life Sciences |
Equity ISIN Code | AU000000MVP2 |
Bond Issue ISIN Code | US460599AD57 |
S&P Rating | Others |
Maturity Date | 15th of January 2027 |
Issuance Date | 26th of September 2018 |
Coupon | 6.25 % |
Medical Developments Outstanding Bond Obligations
Boeing Co 2196 | US097023DG73 | Details | |
HSBC Holdings PLC | US404280DR76 | Details | |
MPLX LP 52 | US55336VAL45 | Details | |
International Game Technology | US460599AD57 | Details | |
MGM Resorts International | US552953CD18 | Details | |
AerCap Global Aviation | US00773HAA59 | Details |
Understaning Medical Developments Use of Financial Leverage
Medical Developments' financial leverage ratio measures its total debt position, including all of its outstanding liabilities, and compares it to Medical Developments' current equity. If creditors own a majority of Medical Developments' assets, the company is considered highly leveraged. Understanding the composition and structure of Medical Developments' outstanding bonds gives an idea of how risky it is and if it is worth investing in.
Last Reported | Projected for Next Year | ||
Short and Long Term Debt Total | 2.3 M | 2.7 M | |
Net Debt | -7.4 M | -7.8 M | |
Short Term Debt | 371 K | 494.4 K | |
Short and Long Term Debt | 81.9 K | 77.8 K | |
Long Term Debt Total | 2.5 M | 2.6 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medical Stock Analysis
When running Medical Developments' price analysis, check to measure Medical Developments' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Developments is operating at the current time. Most of Medical Developments' value examination focuses on studying past and present price action to predict the probability of Medical Developments' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Developments' price. Additionally, you may evaluate how the addition of Medical Developments to your portfolios can decrease your overall portfolio volatility.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.